Home

Canopy Growth Corporation - Common Shares (CGC)

1.9650
-0.0550 (-2.72%)

Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products

The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers.

SummaryNewsPress ReleasesChartHistoricalFAQ
Canopy Growth (CGC) Q3 2025 Earnings Call Transcriptfool.com
CGC earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 10, 2025
Top stock movements in today's session.chartmill.com
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · February 7, 2025
What's going on in today's pre-market sessionchartmill.com
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · February 7, 2025
This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global Newsbenzinga.com
Cannabis news: DeSantis fights Florida's 2026 ballot, US cannabis growth slows, Tilray lands a JetBlue deal, Aurora reports stellar earnings and more.
Via Benzinga · February 7, 2025
Canopy Gwth Q3 Earnings Assessmentbenzinga.com
Via Benzinga · February 7, 2025
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?benzinga.com
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.
Via Benzinga · February 7, 2025
Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday?benzinga.com
Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.
Via Benzinga · February 7, 2025
Earnings Scheduled For February 7, 2025benzinga.com
Via Benzinga · February 7, 2025
The market is filled with gapping stocks in Wednesday's session.chartmill.com
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
Via Chartmill · February 5, 2025
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?benzinga.com
Aurora Cannabis (NASDAQACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Via Benzinga · February 5, 2025
Can Canada Maintain Its Cannabis Edge After Trudeau's Departure?benzinga.com
Trudeau's exit leaves Canada's cannabis industry at a crossroads. Will new leadership support its growth?
Via Benzinga · January 29, 2025
The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And Morebenzinga.com
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates.
Via Benzinga · January 24, 2025
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025benzinga.com
Via Benzinga · January 20, 2025
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And Morebenzinga.com
Cannabis news of the week: New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Via Benzinga · January 10, 2025
Cannabis Stock Movers For January 9, 2025benzinga.com
Via Benzinga · January 9, 2025
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags Onbenzinga.com
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'benzinga.com
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surgebenzinga.com
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.
Via Benzinga · December 9, 2024
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Knowbenzinga.com
Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQCGC) U.S.-domiciled holding company said on Monday. Canopy USA, created in 2022 to streamline the Canadian cannabis giant's entry into the US market, now owns 100% of the issued and outstanding shares of Acreage. The $3.4 billion acquisition deal was first in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured.
Via Benzinga · December 9, 2024
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demandbenzinga.com
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?benzinga.com
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Via Benzinga · December 5, 2024
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flowbenzinga.com
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.
Via Benzinga · December 4, 2024
Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Lossesbenzinga.com
Canopy Growth Corporation (TSX: WEED) (NASDAQCGC) and Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF) announced on Monday that it is anticipated that Canopy USA, LLC will complete its acquisition of Acreage on or around Dec. 9, 2024. The Canadian cannabis giant announced its plans to acquire Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured. The deal outlined the plan to acquire all Class E subordinate voting shares of Acreage. This acquisition will follow the purchase of the Class D shares of Acreage, based on an agreement from October 24, 2022. After both acquisitions are completed, Canopy USA will own all shares of Acreage.
Via Benzinga · December 3, 2024
Cannabis Retailer Tokyo Smoke Moves Forward After Major Restructuringbenzinga.com
Cannabis retailer Tokyo Smoke has finished its restructuring process and is no longer under financial protection, following a court's approval. The Canadian company first announced that it started restructuring its business in August, obtaining an initial order under the Companies Creditors Arrangement Act (CCAA) from the Ontario Superior Court of Justice in Canada. In Sept. the company entered a share subscription agreement with TS Investments Corp., its parent company. Under the deal, TS Investments agreed to subscribe to all of the issued and outstanding shares of Tokyo Smoke. That deal was valued at roughly $56.7 million (CA$77 million).
Via Benzinga · December 2, 2024
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewalbenzinga.com
Via Benzinga · November 27, 2024